Glenmede Trust’s Edgewise Therapeutics EWTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q1	$480K	Sell	21,809 -110	-0.5%	-$2.42K	﹤0.01%	923
2024 Q4	$585K	Buy	21,919 +3,834	+21%	+$102K	﹤0.01%	874
2024 Q3	$483K	Buy	+18,085	New	+$483K	﹤0.01%	943